525 related articles for article (PubMed ID: 10804375)
1. [Polycystic ovary syndrome].
Dewailly D
J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):298-301. PubMed ID: 10804375
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
3. Secondary forms of polycystic ovary syndrome.
Kaltsas GA; Isidori AM; Besser GM; Grossman AB
Trends Endocrinol Metab; 2004 Jul; 15(5):204-10. PubMed ID: 15223049
[TBL] [Abstract][Full Text] [Related]
4. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
Carmina E; Azziz R
Fertil Steril; 2006 Jul; 86 Suppl 1():S7-8. PubMed ID: 16798288
[TBL] [Abstract][Full Text] [Related]
6. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
7. Follicle dynamics and anovulation in polycystic ovary syndrome.
Franks S; Stark J; Hardy K
Hum Reprod Update; 2008; 14(4):367-78. PubMed ID: 18499708
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
Diamanti-Kandarakis E
Expert Rev Mol Med; 2008 Jan; 10():e3. PubMed ID: 18230193
[TBL] [Abstract][Full Text] [Related]
9. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
10. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
11. [Polycystic ovary syndrome and hair unit function disturbances in dermatological practice].
Szpringer EA; Lutnicki KR; Zych IS
Wiad Lek; 2006; 59(11-12):848-54. PubMed ID: 17427503
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovarian syndrome.
Trikudanathan S
Med Clin North Am; 2015 Jan; 99(1):221-35. PubMed ID: 25456652
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome and female reproduction.
Elghblawi E
Br J Nurs; 2007 Oct 11-24; 16(18):1118-21. PubMed ID: 18073681
[TBL] [Abstract][Full Text] [Related]
16. [The role of leptin in polycystic ovary syndrome].
Marciniak A; Starczewski A
Pol Merkur Lekarski; 2008 Oct; 25(148):390-3. PubMed ID: 19145943
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of polycystic ovary syndrome].
Gandar R; Spizzo M; Collin D
J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):510-8. PubMed ID: 10598343
[TBL] [Abstract][Full Text] [Related]
18. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
Hart R; Hickey M; Franks S
Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
[TBL] [Abstract][Full Text] [Related]
19. Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.
Westerveld HE; Hoogendoorn M; de Jong AW; Goverde AJ; Fauser BC; Dallinga-Thie GM
Pharmacol Ther; 2008 Sep; 119(3):223-41. PubMed ID: 18602948
[TBL] [Abstract][Full Text] [Related]
20. The impact of obesity on reproduction in women with polycystic ovary syndrome.
Pasquali R; Gambineri A; Pagotto U
BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]